Influenza Medication Market 2020 Global Industry Analysis by Size, Share, Trends and Growth Forecast to 2026, is latest report published on “Global Influenza Medication Market” by Fortune Business Insights. Report segments comprehensive information about Influenza Medication Market By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026.
An Overview of the Impact of COVID-19 on Influenza Medication Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
“Influenza Medication” Treatment Market 2020 report presents a comprehensive assessment of the global pre filled syringes market by offering valuable insights, Influenza Medication types, facts, industry-related information, and historical data. Several methodologies and approaches are adopted to make meaningful assumptions and views. Furthermore, the report offers a detailed analysis and information as per Influenza Medication manufacturers, market segments helping our readers to get a comprehensive overview of the global market. Several players are planning to focus on developing cost-effective products or services, aiming to maintain a strong foothold in the market.
List of the leading companies that are operating in the global Influenza Medication market are:
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline plc
- Seqirus (CSL)
- Genentech, Inc.
- Macleods Pharmaceuticals Ltd.
- Zydus Pharmaceuticals, Inc.
- Lupin Limited
- Shionogi & Co., Ltd.
Influenza Medication Market Analysis From 2020 To 2026:
The global influenza medication market size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. High prevalence of influenza around the world will be the central growth driver for this market.
Governments, regulatory authorities, academic institutions, and international bodies are undertaking campaigns to promote awareness among the common people about the importance of the influenza vaccine. For instance, the UK’s National Health Service (NHS) has been running the ‘NHS flu fighter’ campaign to encourage frontline healthcare workers to get vaccinated against seasonal influenza epidemic. In Brazil, the national government undertook an extensive immunization campaign in 2011 to vaccinate a wide spectrum of people including healthcare workers, pregnant women, and indigenous people. Similarly, the WHO/Europe launched the Flu Awareness Campaign in 2013 in Europe to boost uptake of the flu vaccine in risk groups by promoting its benefits through fact sheets, advertisements, and communication in local languages. These campaigns are set to play a critical role in the influenza medication market growth in the foreseeable future.
Also known as the flu, influenza is a highly contagious respiratory infection that affects the lungs, throat, and nose and is characterized by sudden fever, dry cough, muscle and joint pain, and headache. The infection is usually seasonal and the World Health Organization (WHO) estimates reveal that yearly epidemics of the flu affect 3 to 5 million people around the world and account for around 290,000 to 650,000 respiratory deaths annually. Thus, one of the major influenza medication market trends is the widespread prevalence of the flu across the globe, which is spiking the demand for influenza drugs and vaccines.
With a market size of USD 527.3 million in 2018, North America is poised to command the influenza medication market share as a result of focused investment in medical and healthcare research in the region. Moreover, the prevalence of influenza A and B has remained consistently high in North America, which has kept the demand for influenza medicines stable for the past few decades. In Asia-Pacific, the market value is expected to further augment owing to increasing prevalence of the infection along with rising mortality rate due to the flu. The market in Europe is anticipated to display impressive growth on account of high incidence of influenza in Western Europe and rising research funding in some of the key countries such as Germany and the UK.
Most of the players in this market are engaged in developing and launching novel drugs and medication to meet the rising need to tackle the seasonal menace of the flu. As a response, bodies such as the Food and Drug Administration (FDA) are providing the necessary regulatory support to these players and encouraging research in the industry.
Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
The Influenza Medication Market Size, Share, Growth report examines competitive scenario by analyzing key players in the market. The company profiling of leading market players is included this report with Porter’s five forces analysis and Value Chain analysis. Further, the strategies exercised by the companies for expansion of business through mergers, acquisitions, and other business development measures are discussed in the report. The financial parameters which are assessed include the sales, profits and the overall revenue generated by the key players of Market.
Report Analyzes Market Opportunity By Following Region Regional Market Overview:
- North America (the United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Turkey, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
- South America (Brazil etc.)
- The Middle East and Africa (North Africa and GCC Countries)
Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
Table of Content:
- Report Introduction
- Market Introduction
- Scope Of The Study
- Research Objective
- Research Methodology
- Primary Research
- Secondary Research
- Market Size Estimation
- Market Dynamics
- Macroeconomic Indicators
- Technology Trends and Assessment
- Market Factor Analysis
- Porter’s Five Forces Analysis
- Bargaining Power Of Suppliers
- Bargaining Power Of Buyers
- Threat Of New Entrants
- Threat Of Substitutes
- Intensity Of Rivalry
- Value Chain Analysis
- Investment Feasibility Analysis
- Pricing Analysis
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune -411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245